Cipla Q4 Results
- BSE: 500087
- NSE: CIPLA
- ISIN: INE059A01026
- Sector: Biotechnology & Drugs
BSE
1,365
-15.00 (-1.09%)
-15.00 (-1.09%)Volume33.82 K
Updated: Fri 11 Sep, 2026 | 15:28:41
NSE
1,366.00-7.30 (-0.53%)
-7.30 (-0.53%)Volume1.68 M
Updated: Fri 11 Sep, 2026 | 15:50:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Cipla Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 5,969.17 | 6,373.68 | -6.35% | 5,135.72 | 8.51% |
| Depreciation/ Amortization | 382.92 | 278.35 | 37.57% | 288.34 | 24.03% |
| Operating Income | 572.03 | 700.80 | -18.37% | 1,027.52 | -53.45% |
| Net Income | 554.64 | 675.80 | -17.93% | 939.04 | -54.61% |
| Other Operating Expenses Total | 1,881.30 | 1,862.36 | 1.02% | 1,713.03 | 6.29% |
| Net Income Before Taxes | 707.06 | 893.11 | -20.83% | 1,259.26 | -53.00% |
| Total Revenue | 6,541.20 | 7,074.48 | -7.54% | 6,163.24 | -2.80% |
| Selling/ General/ Admin Expenses Total | 1,414.25 | 1,324.98 | 6.74% | 1,084.23 | 14.69% |
| Diluted Normalized EPS | 7.27 | 10.94 | -33.55% | 11.63 | -51.92% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.